[引用][C] Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis
TJ Smith, BE Hillner, CE Desch - JNCI: Journal of the National …, 1993 - academic.oup.com
Cancer care direct costs comprised 10.7% of all medical care costs in 1985 (7) and were
estimated at $35 billion in 1990 (2). Oncology physician charges increased by …
estimated at $35 billion in 1990 (2). Oncology physician charges increased by …
Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument
LM Elit, MN Levine, A Gafni, TJ Whelan, G Doig… - Gynecologic …, 1996 - Elsevier
The objective of this study was to determine a patient's preference for treatment in the poor
prognostic situation of advanced epithelial ovarian cancer. A standardized method of …
prognostic situation of advanced epithelial ovarian cancer. A standardized method of …
Palliative chemotherapy or watchful waiting? A vignettes study among oncologists
CG Koedoot, J De Haes, SH Heisterkamp… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: To determine the preferences of oncologists for palliative chemotherapy or
watchful waiting and the factors considered important to that preference. METHODS: Sixteen …
watchful waiting and the factors considered important to that preference. METHODS: Sixteen …
The decision evaluation scales
PFM Stalmeier, MS Roosmalen, LCG Verhoef… - Patient Education and …, 2005 - Elsevier
There are several instruments to assess how patients evaluate their medical treatment
choice. These are used to evaluate decision aids. Our objective is to investigate which …
choice. These are used to evaluate decision aids. Our objective is to investigate which …